Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06528691
Title Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors St. Jude Children's Research Hospital
Indications
Therapies
Age Groups: child
Covered Countries USA

Additional content available in CKB BOOST